XML 50 R39.htm IDEA: XBRL DOCUMENT
v3.26.1

COMMON STOCK OPTIONS, WARRANTS AND RESTRICTED STOCK (Tables) | 3 Months Ended
--- | ---
Mar. 31, 2026
Share-Based Payment Arrangement [Abstract] |
Schedule of options activity |
Schedule of options activity |  |  |  |  |  |  |  |  |  |  |  |  |
|  |  | Shares |  |  | Weighted Average Exercise Price |  |  | Weighted Average Remaining Contractual Term (Years) |  |  | Aggregate Intrinsic Value |
| Outstanding at December 31, 2024 |  |  |  | 606,452 |  |  | $ | 5.29 |  |  |  | 2.0 |  |  | $ | 514,394 |
| Granted |  |  |  | 20,000 |  |  | $ | 5.64 |  |  |  | 2.5 |  |  | $ | 112,200 |
| Forfeited |  |  |  | (271,449 | ) |  | $ | 5.71 |  |  |  | — |  |  | $ | — |
| Outstanding at December 31, 2025 |  |  |  | 355,003 |  |  | $ | 5.00 |  |  |  | 1.8 |  |  | $ | 2,219,665 |
| Exercisable at December 31, 2025 |  |  |  | 283,000 |  |  | $ | 5.15 |  |  |  | 1.5 |  |  | $ | 1,727,688 |
| Outstanding at December 31, 2025 |  |  |  | 355,003 |  |  | $ | 5.00 |  |  |  | 1.8 |  |  | $ | 2,219,665 |
| Granted |  |  |  | 5,000 |  |  | $ | 11.44 |  |  |  | 4.8 |  |  | $ | — |
| Exercised |  |  |  | (15,000 | ) |  | $ | 4.69 |  |  |  | — |  |  | $ | — |
| Forfeited/Expired |  |  |  | (20,000 | ) |  | $ | 4.18 |  |  |  | — |  |  | $ | — |
| Outstanding at March 31, 2026 |  |  |  | 325,003 |  |  | $ | 5.16 |  |  |  | 1.8 |  |  | $ | 575,104 |
| Exercisable at March 31, 2026 |  |  |  | 251,334 |  |  | $ | 5.24 |  |  |  | 1.5 |  |  | $ | 408,018 |
Schedule of fair value of warrants |
Schedule of fair value of warrants |  |  |  |  |  |
|  | For the Three Months Ended March 31, |
|  | 2026 |  |  | 2025 |
Stock price |  | $ | 11.25 |  |  | $ | — |
Exercise Price |  | $ | 11.44 |  |  | $ | — |
Risk free interest rate |  |  | 3.55 | % |  |  | — |
Expected term in years |  |  | 5 |  |  |  | — |
Dividend yield |  |  | — |  |  |  | — |
Volatility of common stock |  |  | 93.67 | % |  |  | — |
Schedule of assumptions |
Schedule of assumptions |  |  |
Date of Grant |  | March 2, 2026 |
Stock Price |  | $ | 7.61 |
Exercise Price |  | $ | 9.00 |
Expected Remaining Term (Years) |  |  | 5.00 |
Expected Volatility |  |  | 92 | %
Dividend Yield |  |  | 0 | %
Discount Rate - Bond Equivalent Yield |  |  | 3.620 | %
Schedule of warrants outstanding |
Schedule of warrants outstanding |  |  |  |  |  |  |  |  |  |  |  |
|  | Number of Warrants |  |  | Weighted Average Exercise Price |  |  | Weighted Average Remaining Contractual Term (Years) |  |  | Aggregate Intrinsic Value |
Outstanding at December 31, 2024 |  |  | — |  |  | $ | — |  |  |  | — |  |  | $ | — |
Warrants expired, forfeited, cancelled or exercised |  |  | — |  |  | $ | — |  |  |  | — |  |  | $ | — |
Warrants issued |  |  | 375,276 |  |  | $ | 7.20 |  |  |  | 5.0 |  |  | $ | — |
Outstanding at December 31, 2025 |  |  | 375,276 |  |  | $ | 7.20 |  |  |  | 4.6 |  |  | $ | 1,519,868 |
Exercisable at December 31, 2025 |  |  | 375,276 |  |  | $ | 7.20 |  |  |  | 4.6 |  |  | $ | 1,519,868 |
Outstanding at December 31, 2025 |  |  | 375,276 |  |  | $ | 7.20 |  |  |  | 4.6 |  |  | $ | 1,519,868 |
Warrants expired, forfeited, cancelled or exercised |  |  | — |  |  | $ | — |  |  |  | — |  |  | $ | — |
Warrants issued |  |  | 433,334 |  |  | $ | 9.00 |  |  |  | 5.0 |  |  | $ | — |
Outstanding at March 31, 2026 |  |  | 808,610 |  |  | $ | 8.16 |  |  |  | 4.7 |  |  | $ | — |
Exercisable at March 31, 2026 |  |  | 808,610 |  |  | $ | 8.16 |  |  |  | 4.7 |  |  | $ | — |
Schedule of restricted stock |
Schedule of restricted stock |  |  |  |  |  |
|  | Number of Shares |  |  | Weighted Average Grant Date Fair Value Per Share |
Unvested at December 31, 2024 |  |  | — |  |  | $ | — |
Restricted stock granted |  |  | 2,146,898 |  |  | $ | 6.13 |
Restricted stock forfeited |  |  | (162,500 | ) |  | $ | 6.00 |
Restricted stock vested |  |  | (20,000 | ) |  | $ | 5.22 |
Unvested at December 31, 2025 |  |  | 1,964,398 |  |  | $ | 6.15 |
Vested at December 31, 2025 |  |  | 20,000 |  |  | $ | 5.22 |
Unvested at December 31, 2025 |  |  | 1,964,398 |  |  | $ | 6.15 |
Restricted stock granted |  |  | 420,000 |  |  | $ | 10.70 |
Restricted stock forfeited |  |  | — |  |  | $ | — |
Restricted stock vested |  |  | (10,000 | ) |  | $ | 5.98 |
Unvested at March 31, 2026 |  |  | 2,374,398 |  |  | $ | 6.95 |
Vested at March 31, 2026 |  |  | 30,000 |  |  | $ | 5.47 |

X
- References No definition available. + Details
Name: | duot_ScheduleOfFairValueWarrantsTableTextBlock
Namespace Prefix: | duot_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of assumption used to determine benefit obligation and net periodic benefit cost of defined benefit plan. Includes, but is not limited to, discount rate, rate of compensation increase, expected long-term rate of return on plan assets and interest crediting rate. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 715 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 5 -Subparagraph (j) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480506/715-20-50-5 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 715 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (k) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480506/715-20-50-1 + Details
Name: | us-gaap_ScheduleOfAssumptionsUsedTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of cash and cash equivalents restricted as to withdrawal or usage. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 944 -SubTopic 210 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-03(a)(2)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 942 -SubTopic 210 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.9-03(1)(a)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 8 -SubTopic 10 -Topic 230 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482913/230-10-50-8 + Details
Name: | us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (d) -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (e) -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3 + Details
Name: | us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration